| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-776-68 | 62135-776 | HUMAN PRESCRIPTION DRUG | AMOXICILLIN | Amoxicillin | POWDER, FOR SUSPENSION | ORAL | 20231215 | N/A | ANDA | ANDA062059 | Chartwell RX, LLC | AMOXICILLIN | 125 mg/5mL | 80 mL in 1 BOTTLE (62135-776-68) |
| 62135-777-38 | 62135-777 | HUMAN PRESCRIPTION DRUG | AMOXICILLIN | Amoxicillin | POWDER, FOR SUSPENSION | ORAL | 20231215 | N/A | ANDA | ANDA062059 | Chartwell RX, LLC | AMOXICILLIN | 250 mg/5mL | 150 mL in 1 BOTTLE (62135-777-38) |
| 62135-777-42 | 62135-777 | HUMAN PRESCRIPTION DRUG | AMOXICILLIN | Amoxicillin | POWDER, FOR SUSPENSION | ORAL | 20231215 | N/A | ANDA | ANDA062059 | Chartwell RX, LLC | AMOXICILLIN | 250 mg/5mL | 100 mL in 1 BOTTLE (62135-777-42) |
| 62135-777-68 | 62135-777 | HUMAN PRESCRIPTION DRUG | AMOXICILLIN | Amoxicillin | POWDER, FOR SUSPENSION | ORAL | 20231215 | N/A | ANDA | ANDA062059 | Chartwell RX, LLC | AMOXICILLIN | 250 mg/5mL | 80 mL in 1 BOTTLE (62135-777-68) |
| 62135-776-42 | 62135-776 | HUMAN PRESCRIPTION DRUG | AMOXICILLIN | Amoxicillin | POWDER, FOR SUSPENSION | ORAL | 20231215 | N/A | ANDA | ANDA062059 | Chartwell RX, LLC | AMOXICILLIN | 125 mg/5mL | 100 mL in 1 BOTTLE (62135-776-42) |
| 62135-776-38 | 62135-776 | HUMAN PRESCRIPTION DRUG | AMOXICILLIN | Amoxicillin | POWDER, FOR SUSPENSION | ORAL | 20231215 | N/A | ANDA | ANDA062059 | Chartwell RX, LLC | AMOXICILLIN | 125 mg/5mL | 150 mL in 1 BOTTLE (62135-776-38) |